Cell Therapy Development

Leveraging the power of induced pluripotent stem cells (iPSCs) for cell therapies with the potential to fulfill unmet medical needs.

Innovation designed to address diseases

Every day patients worldwide are diagnosed with diseases with few treatment options available. While many existing therapies aim to stop disease progression and silence symptoms, we don’t think that is enough.

FUJIFILM Cellular Dynamics Inc. is working to improve today’s therapies to address unmet needs and improve how patients are treated. That is why we are focusing on developing off-the-shelf allogeneic cell therapy candidates in the areas of ocular diseases, heart failure, immuneoncology and Parkinson’s disease.

We continue to make critical investments in enhancing cell therapy efforts including the opening of our 32,000 square-foot cell therapy cGMP manufacturing facility in Madison, Wisconsin, and new projects, such as Opsis Therapeutics, a joint venture focused on regenerative medicine therapies, including macular degeneration, retinitis pigmentosa and cone dystrophies.

Looking ahead, we will expand on developing cell therapies, an unprecedented opportunity to participate in the front ranks of a revolution in treating diseases with unmet needs.

Learn More

FUJIFILM Cellular Dynamics, Inc.